Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 765950, 6 pages
http://dx.doi.org/10.1155/2015/765950
Clinical Study

Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years

1Thyroid Outpatient Department, Bugat Hospital, 6 Fenyves Street, Gyongyos, Matrafured 3232, Hungary
2Department of Obstetrics and Gynecology, Semmelweis University, Üllői Street 78/A, Budapest 1082, Hungary
3Division of Endocrinology, Medical Centre of Hungarian Defense Forces, 44 Robert Karoly Avenue, Budapest 1134, Hungary
4Division of Endocrinology, Department of Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Square 94, Debrecen 4032, Hungary

Received 5 July 2015; Revised 23 October 2015; Accepted 3 November 2015

Academic Editor: Andrea G. Lania

Copyright © 2015 Tamas Solymosi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tamas Solymosi, Zsolt Melczer, Istvan Szabolcs, Endre V. Nagy, and Miklos Goth, “Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years,” International Journal of Endocrinology, vol. 2015, Article ID 765950, 6 pages, 2015. https://doi.org/10.1155/2015/765950.